Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
44.8 (1y: +9%)
Market Cap 15.29 B P/E(ttm) 15.50
Enterprise Value 15.12 B P/B 3.00
A- NYSE (USA)
Agilent Technologies Inc
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$44.80
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry		 vs
history
Cash to Debt 0.995
A's Cash to Debt is ranked lower than
57% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.01 vs. A: 0.995 )
A' s 10-Year Cash to Debt Range
Min: 0.67   Max: No Debt
Current: 1
Equity to Asset 0.492
A's Equity to Asset is ranked lower than
54% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.57 vs. A: 0.492 )
A' s 10-Year Equity to Asset Range
Min: 0.33   Max: 0.71
Current: 0.49
0.33
0.71
Interest Coverage 12.2
A's Interest Coverage is ranked higher than
59% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 10.50 vs. A: 12.2 )
A' s 10-Year Interest Coverage Range
Min: 1   Max: No Debt
Current: 12.2
F-Score: 5
Z-Score: 3.73
M-Score: -2.3
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry		 vs
history
Operating margin (%) 16.30
A's Operating margin (%) is ranked higher than
93% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.90 vs. A: 16.30 )
A' s 10-Year Operating margin (%) Range
Min: -26.7   Max: 16.3
Current: 16.3
-26.7
16.3
Net-margin (%) 16.8
A's Net-margin (%) is ranked higher than
95% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.00 vs. A: 16.8 )
A' s 10-Year Net-margin (%) Range
Min: -34   Max: 66.5
Current: 16.8
-34
66.5
ROE (%) 22.3
A's ROE (%) is ranked higher than
96% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 3.70 vs. A: 22.3 )
A' s 10-Year ROE (%) Range
Min: -72.9   Max: 90.7
Current: 22.3
-72.9
90.7
ROA (%) 10.9
A's ROA (%) is ranked higher than
94% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 2.10 vs. A: 10.9 )
A' s 10-Year ROA (%) Range
Min: -32.7   Max: 44.9
Current: 10.9
-32.7
44.9
ROC (Joel Greenblatt) (%) 62.20
A's ROC (Joel Greenblatt) (%) is ranked higher than
96% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 7.30 vs. A: 62.20 )
A' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -66   Max: 73.2
Current: 62.2
-66
73.2
Revenue Growth (%) 10.7
A's Revenue Growth (%) is ranked higher than
90% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.00 vs. A: 10.7 )
A' s 10-Year Revenue Growth (%) Range
Min: -14.3   Max: 10.9
Current: 10.7
-14.3
10.9
EBITDA Growth (%) 60.9
A's EBITDA Growth (%) is ranked higher than
99% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.00 vs. A: 60.9 )
A' s 10-Year EBITDA Growth (%) Range
Min: -19.7   Max: 60.9
Current: 60.9
-19.7
60.9
» A's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

A Guru Trades in Q2 2012

Paul Tudor Jones 29,600 sh (New)
Richard Snow 358,935 sh (New)
Joel Greenblatt 85,185 sh (+519.12%)
Ray Dalio 238,131 sh (+417.33%)
Scott Black 174,150 sh (+34.56%)
Pioneer Investments 1,678,351 sh (+7.44%)
David Dreman 74,613 sh (+1.1%)
Dodge & Cox 5,303 sh (unchged)
Robert Olstein 165,000 sh (unchged)
Ron Baron 19,000 sh (unchged)
John Keeley 8,780 sh (unchged)
Bruce Kovner Sold Out
John Hussman Sold Out
PRIMECAP Management 110,298 sh (-5.85%)
Chris Davis 5,738,892 sh (-6.19%)
Steven Cohen 71,670 sh (-75.45%)
Louis Moore Bacon 50,000 sh (-80%)
» More
Q3 2012

A Guru Trades in Q3 2012

Jim Simons 311,700 sh (New)
Sarah Ketterer 261,790 sh (New)
Michael Price 100,200 sh (New)
Vanguard Health Care Fund 500,000 sh (New)
Steven Cohen 819,685 sh (+1043.69%)
Richard Snow 1,072,476 sh (+198.79%)
Robert Olstein 204,000 sh (+23.64%)
David Dreman 85,939 sh (+15.18%)
Scott Black 196,060 sh (+12.58%)
Ron Baron 19,000 sh (unchged)
Dodge & Cox 5,303 sh (unchged)
Ray Dalio Sold Out
John Keeley Sold Out
Paul Tudor Jones Sold Out
Louis Moore Bacon Sold Out
PRIMECAP Management 106,698 sh (-3.26%)
Chris Davis 5,057,949 sh (-11.87%)
Pioneer Investments 1,205,268 sh (-28.19%)
Joel Greenblatt 24,179 sh (-71.62%)
» More
Q4 2012

A Guru Trades in Q4 2012

George Soros 275,000 sh (New)
Brian Rogers 2,250,000 sh (New)
Bruce Kovner 30,000 sh (New)
Louis Moore Bacon 250,000 sh (New)
Jim Simons 1,174,500 sh (+276.8%)
Vanguard Health Care Fund 1,300,000 sh (+160%)
Sarah Ketterer 552,300 sh (+110.97%)
Richard Snow 1,408,464 sh (+31.33%)
Scott Black 201,270 sh (+2.66%)
Robert Olstein 208,000 sh (+1.96%)
PRIMECAP Management 106,698 sh (unchged)
Ron Baron 19,000 sh (unchged)
Dodge & Cox 5,303 sh (unchged)
Michael Price Sold Out
David Dreman 82,481 sh (-4.02%)
Chris Davis 4,734,121 sh (-6.4%)
Joel Greenblatt 14,694 sh (-39.23%)
Pioneer Investments 631,153 sh (-47.63%)
Steven Cohen 8,486 sh (-98.96%)
» More
Q1 2013

A Guru Trades in Q1 2013

Paul Tudor Jones 550,000 sh (New)
Jean-Marie Eveillard 1,348,846 sh (New)
Steven Cohen 650,682 sh (+7567.71%)
Bruce Kovner 150,000 sh (+400%)
Vanguard Health Care Fund 6,416,100 sh (+393.55%)
Ron Baron 23,000 sh (+21.05%)
Sarah Ketterer 578,500 sh (+4.74%)
Dodge & Cox 5,303 sh (unchged)
Brian Rogers 2,250,000 sh (unchged)
Louis Moore Bacon Sold Out
Jim Simons Sold Out
George Soros Sold Out
Richard Snow 1,374,504 sh (-2.41%)
David Dreman 75,717 sh (-8.2%)
PRIMECAP Management 96,057 sh (-9.97%)
Robert Olstein 174,000 sh (-16.35%)
Joel Greenblatt 12,018 sh (-18.21%)
Chris Davis 3,812,222 sh (-19.47%)
Scott Black 146,783 sh (-27.07%)
Pioneer Investments 387,190 sh (-38.65%)
» More
» Details

Insider Trades

Latest Guru Trades with A

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Vanguard Health Care Fund 2013-03-31 Add 393.55%0.88%$40.94 - $45.29 $ 44.84%6416100
Scott Black 2013-03-31 Reduce -27.07%0.32%$40.94 - $45.29 $ 44.84%146783
Jean-Marie Eveillard 2013-03-31 New Buy0.19%$40.94 - $45.29 $ 44.84%1348846
George Soros 2013-03-31 Sold Out 0.13%$40.94 - $45.29 $ 44.84%0
Ron Baron 2013-03-31 Add 21.05%$40.94 - $45.29 $ 44.84%23000
Michael Price 2012-12-31 Sold Out 0.57%$35.51 - $41.39 $ 44.818%0
George Soros 2012-12-31 New Buy0.13%$35.51 - $41.39 $ 44.818%275000
Vanguard Health Care Fund 2012-12-31 Add 160%0.09%$35.51 - $41.39 $ 44.818%1300000
Joel Greenblatt 2012-12-31 Reduce -39.23%0.02%$35.51 - $41.39 $ 44.818%14694
Michael Price 2012-09-30 New Buy0.57%$35.59 - $40.75 $ 44.817%100200
Joel Greenblatt 2012-09-30 Reduce -71.62%0.18%$35.59 - $40.75 $ 44.817%24179
Ray Dalio 2012-09-30 Sold Out 0.14%$35.59 - $40.75 $ 44.817%0
Scott Black 2012-09-30 Add 12.58%0.12%$35.59 - $40.75 $ 44.817%196060
Vanguard Health Care Fund 2012-09-30 New Buy0.09%$35.59 - $40.75 $ 44.817%500000
John Keeley 2012-09-30 Sold Out 0.01%$35.59 - $40.75 $ 44.817%0
John Hussman 2012-06-30 Sold Out 0.86%$37.65 - $44.91 $ 44.810%0
Scott Black 2012-06-30 Add 34.56%0.28%$37.65 - $44.91 $ 44.810%174150
Joel Greenblatt 2012-06-30 Add 519.12%0.21%$37.65 - $44.91 $ 44.810%85185
Ray Dalio 2012-06-30 Add 417.33%0.11%$37.65 - $44.91 $ 44.810%238131
Premium More recent guru trades are included for Premium Members only!!
» Financial Charts

Peter Lynch Chart

Top Ranked Articles about Agilent Technologies Inc

Edward Owens’ 3 Biggest Stock Increases
February 5, 2013
Edward Owens - Edward Owens’ 3 Biggest Stock Increases
Edward Owens left his Vanguard Health Fund at the end of 2012 after an illustrious career. The $23.1 billion fund has returned 16.46% on average annually since inception in 1984, outdoing its benchmark Spliced Health Care Index benchmark’s 10.71% and every other U.S. equity mutual fund, according to Bloomberg. Jean M. Hynes, CFA, a Wellington senior vice president, partner and global industry analyst with the firm since 2008, succeeds him in leading the fund. In the fourth quarter, Owens’ last at the fund, he bought no new stocks but added to preexisting holdings. His largest increases were: Agilent Technologies (A), Allscripts-Misys Healthcare Solutions (MDRX) and Teva Pharmaceuticals Ltd. (TEVA). Read more...
Best Mutual Fund Manager Edward Owens Buys 1 New Stock, Reports Holding Increases
November 1, 2012
Edward Owens - Best Mutual Fund Manager Edward Owens Buys 1 New Stock, Reports Holding Increases
Edward Owens, manager of Vanguard’s $22.4 billion Health Care Fund (VGHCX), will retire at the end of the year, after outperforming every U.S. equity mutual fund since his fund’s inception in 1984. Owens’ fund returned 16 percent annually since 1984, compared to the S&P 500’s 11 percent annual return over the same period, according to Bloomberg. The third quarter continued Owen’s trend of making few changes to his health care portfolio. The value investor bought one new stock, Aglient Technologies Inc. (A) and made small increases to existing holdings, the largest of which are Teva Pharmaceuticals Industries (TEVA) and Green Mountain Coffee Roasters (GMCR). Read more...

Ratios

vs
industry		 vs
history
P/E(ttm) 15.50
A's P/E(ttm) is ranked higher than
63% of the 1680 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 17.60 vs. A: 15.50 )
A' s 10-Year P/E(ttm) Range
Min: 3.84   Max: 91.02
Current: 15.5
3.84
91.02
P/B 3.00
A's P/B is ranked lower than
72% of the 2254 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.18 vs. A: 3.00 )
A' s 10-Year P/B Range
Min: 1.03   Max: 13.12
Current: 3
1.03
13.12
P/S 2.28
A's P/S is ranked lower than
68% of the 2325 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.80 vs. A: 2.28 )
A' s 10-Year P/S Range
Min: 0.79   Max: 4.84
Current: 2.28
0.79
4.84
PFCF 14.60
A's PFCF is ranked higher than
59% of the 1456 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 15.00 vs. A: 14.60 )
A' s 10-Year PFCF Range
Min: 7.53   Max: 933.42
Current: 14.6
7.53
933.42
EV-to-EBIT 15.4
A's EV-to-EBIT is ranked higher than
54% of the 1623 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 13.68 vs. A: 15.4 )
A' s 10-Year EV-to-EBIT Range
Min: 7.7   Max: 341.9
Current: 15.4
7.7
341.9
PEG 0.5
A's PEG is ranked higher than
85% of the 480 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.43 vs. A: 0.5 )
A' s 10-Year PEG Range
Min: 0.31   Max: 8.15
Current: 0.5
0.31
8.15
Shiller P/E 22.2
A's Shiller P/E is ranked lower than
100% of the Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: vs. A: 22.2 )
A' s 10-Year Shiller P/E Range
Min: 8.91   Max: 125.74
Current: 22.2
8.91
125.74

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 0.94
A's Dividend Yield is ranked higher than
52% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.91 vs. A: 0.94 )
A' s 10-Year Dividend Yield Range
Min: 0.22   Max: 1.02
Current: 0.94
0.22
1.02
Dividend Payout 0.1459
A's Dividend Payout is ranked higher than
94% of the 1086 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.40 vs. A: 0.1459 )
A' s 10-Year Dividend Payout Range
Min: 0.09   Max: 0.09
Current: 0.15
Yield on cost (5-Year) 1.00
A's Yield on cost (5-Year) is ranked higher than
55% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.74 vs. A: 1.00 )
A' s 10-Year Yield on cost (5-Year) Range
Min: 0.22   Max: 1.02
Current: 1
0.22
1.02
Share Buyback Rate -0.5
A's Share Buyback Rate is ranked lower than
61% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.00 vs. A: -0.5 )
A' s 10-Year Share Buyback Rate Range
Min: 7.2   Max: -1.8
Current: -0.5

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 13.1
A's Price/Net Current Asset Value is ranked lower than
59% of the 2001 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 6.30 vs. A: 13.1 )
A' s 10-Year Price/Net Current Asset Value Range
Min: 4.2   Max: 17.9
Current: 13.1
4.2
17.9
Price/Tangible Book 14.5
A's Price/Tangible Book is ranked lower than
82% of the 2097 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.30 vs. A: 14.5 )
A' s 10-Year Price/Tangible Book Range
Min: 1.5   Max: 11.9
Current: 14.5
1.5
11.9
Price/DCF (Projected) 1.3
A's Price/DCF (Projected) is ranked higher than
61% of the 638 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.20 vs. A: 1.3 )
A' s 10-Year Price/DCF (Projected) Range
Min: 1.1   Max: 3.9
Current: 1.3
1.1
3.9
Price/Median PS Value 1.1
A's Price/Median PS Value is ranked lower than
52% of the 2138 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.00 vs. A: 1.1 )
A' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 1.4
Current: 1.1
0.5
1.4
Price/Peter Lynch Fair Value 0.6
A's Price/Peter Lynch Fair Value is ranked higher than
81% of the 256 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.10 vs. A: 0.6 )
A' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.5   Max: 2.3
Current: 0.6
0.5
2.3
Price/Graham Number 3
A's Price/Graham Number is ranked lower than
74% of the 1505 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 1.10 vs. A: 3 )
A' s 10-Year Price/Graham Number Range
Min: 1.5   Max: 4.4
Current: 3
1.5
4.4
Earnings Yield (Greenblatt) 6.50
A's Earnings Yield (Greenblatt) is ranked higher than
69% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 4.30 vs. A: 6.50 )
A' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.3   Max: 13
Current: 6.5
0.3
13
Forward Rate of Return (Yacktman) 31.56
A's Forward Rate of Return (Yacktman) is ranked higher than
98% of the 2479 Companies
in the Global Scientific & Technical Instruments industry.

( Industry Median: 0.00 vs. A: 31.56 )
A' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -0.9   Max: 33.9
Current: 31.56
-0.9
33.9

Business Description

Agilent Technologies, Inc. was incorporated in Delaware in May 1999. The company is a measurement company, providing core bio-analytical and electronic measurement solutions to the life sciences, chemical analysis, communications and electronics industries. The three operating segments are: Life sciences business provides application-focused solutions that include instruments, software, consumables, and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Key product categories in life sciences include: DNA and RNA microarrays and associated scanner, software, and reagents; microfluidics-based sample analysis systems; liquid chromatography systems, columns and components; liquid chromatography mass spectrometry systems; capillary electrophoresis systems; laboratory software and informatics systems; bio-reagents and related products; laboratory automation and robotic systems, dissolution testing; Nuclear Magnetic Resonance and Magnetic Resonance Imaging systems along with X-Ray crystallography, and services and support for the aforementioned products; The chemical analysis business provides application-focused solutions that include instruments, software, consumables, and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Key product categories in chemical analysis include: gas chromatography systems, columns and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; and its Electronic measurement business segment provides electronic measurement instruments and systems, software design tools and related services that are used in the design, development, manufacture, installation, deployment and operation of electronics equipment, and microscopy products. Related services include start-up assistance, instrument productivity and application services and instrument calibration and repair. The Company's primary competitors are Keithley Instruments, Inc., Orbotech Ltd., Teradyne, Inc., TRI Test Research Inc., Zygo Corporation, Life Technologies Corp., Perkin Elmer Corp., Shimadzu Corporation, Thermo Fisher Scientific Inc. Varian, Inc., Aeroflex Incorporated, Anritsu Corporation, Ansoft Corporation (a subsidiary of Ansys Corporation), Applied Wave Research, Inc., EXFO Electro-Optical Engineering, Inc., JDS Uniphase, Rohde & Schwartz GmbH & Co. KG, Spirent plc and Tektronix, Inc. The Company's businesses are subject to various significant international, federal, state and local regulations, including but not limited to health and safety, packaging, product content, labor and import/export regulations.
Company Website
SEC Reports
Industry: Scientific & Technical Instruments
Compare:ROP, GRMN, HXGBY, TRMB, NANO
Traded in other countries:AG8.Germany
» More Articles for A

Headlines

Articles On GuruFocus.com
The Best Yielding Ex-Dividend Stocks on March 28, 2013 Mar 27 2013 
comment on A Mar 15 2013 
comment on A Mar 15 2013 
Edward Owens’ 3 Biggest Stock Increases Feb 05 2013 
My 4 Favorites of the 32 Stocks with Dividend Growth from Last Week Jan 20 2013 
comment on A Sep 20 2012 
Value Investor Robert Olstein: Market Is Overreacting and His Top Picks Aug 10 2012 
Comment for A Stock Quote - Agilent Tech Stock News, Research Jun 15 2012 
Dodge & Cox Buy Three New Positions: A, MCO, SPY May 11 2012 
Money Manager and Economist John Hussman’s Top Three New Buys: A, HSY, IP May 02 2012 

More From Our Partners
Cramer's 'Mad Money' Recap: Buys Amid the Rubble Jun 18 2013 - THESTREET

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK